A yeast chemical genetics approach identifies the compound 3,4,5-trimethoxybenzyl isothiocyanate as a calcineurin inhibitor

FEBS Lett. 2014 Jan 31;588(3):455-8. doi: 10.1016/j.febslet.2013.12.006. Epub 2013 Dec 24.

Abstract

The phosphatase enzyme calcineurin controls gene expression in a variety of biological contexts however few potent inhibitors are currently available. A screen of 360 plant extracts for inhibition of calcineurin-dependent gene expression in the model organism Saccharomyces cerevisiae identified the compound 3,4,5-trimethoxybenzyl isothiocyanate as an inhibitor. The compound was subsequently shown to inhibit human calcineurin via a mixed inhibition mechanism. To gain further mechanistic insight a yeast haploinsufficiency screen of 1152 deletion strains was carried out using a novel liquid medium screening method. The resulting haploinsufficiency profile is similar to that reported for the known calcineurin inhibitor FK506.

Keywords: 3,4,5-Trimethoxybenzyl isothiocyanate; Calcineurin; Haploinsufficiency screen; Iberis saxatilis; Yeast.

Publication types

  • Research Support, Non-U.S. Gov't

MeSH terms

  • Calcineurin / biosynthesis*
  • Calcineurin Inhibitors
  • Cell Line
  • Enzyme Inhibitors
  • Gallic Acid / analogs & derivatives*
  • Gallic Acid / chemistry
  • Gallic Acid / isolation & purification
  • Gene Expression Regulation, Fungal / drug effects*
  • Humans
  • Immunosuppressive Agents / pharmacology
  • Plant Extracts / chemistry
  • Plant Extracts / pharmacology*
  • Saccharomyces cerevisiae / drug effects
  • Saccharomyces cerevisiae / genetics
  • Tacrolimus / pharmacology

Substances

  • Calcineurin Inhibitors
  • Enzyme Inhibitors
  • Immunosuppressive Agents
  • Plant Extracts
  • Gallic Acid
  • Calcineurin
  • 3,4,5-trimethoxybenzoic acid
  • Tacrolimus